As part of its series of interviews with CDC staff working on global HIV and tuberculosis (TB) research and development, the Center for Global Health Policy’s “Science Speaks” blog spoke with Jordan Tappero, “who is currently serving as director for the Health Systems Reconstruction Office in the Center for Global Health, an office opened in response to the January 2010 earthquake in Haiti.” In the interview, “Tappero describes his early research in HIV and TB, thoughts on why Uganda is the only sub-Saharan African country not enjoying a reduction in HIV incidence, and how quickly HIV services were restored to people living in Haiti after the January 2010 earthquake,” according to the blog (Mazzotta, 2/29).
“The Kenyan government’s recent failure to adequately treat a patient with extensively drug-resistant tuberculosis (XDR-TB) has some civil society organizations questioning whether the country’s TB program is equipped to diagnose and treat such patients,” PlusNews reports. “The government admits the TB program in Kenya has not been adequately funded despite the country’s big TB burden,” PlusNews writes, adding, “Kenya ranks 13th on the list of 22 high-burden TB countries in the world and has the fifth-highest burden in Africa.”
In an interview with Xinhua on Tuesday, Francis Adatu, head of the national leprosy and tuberculosis (TB) program in Uganda, warned that TB “remains a major public health problem” and that multidrug-resistant TB (MDR-TB) has emerged in the country, the news service writes. “‘According to our prevalence survey we found MDR-TB in 1.3 percent among new cases and 12.3 percent among people who have been exposed to drugs or treated over and over again,’ Adatu said,” Xinhua writes, noting that Adatu said treatment for MDR-TB was much more expensive than for drug-susceptible TB.
The Global Health Technologies Coalition (GHTC) — consisting of 40 global health research and advocacy organizations — on Tuesday held a congressional briefing to launch its third annual policy report, titled “Sustaining Progress: Creating U.S. policies to spur global health innovation,” GlobalPost’s “Global Pulse” blog reports (Donnelly, 2/28). The group is “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria,” VOA News writes (DeCapua, 2/28).
Two new reports from southern Africa’s Health Systems Trust show that pregnant women, infants, and people newly diagnosed with HIV infection are receiving more services, but the costs of care are increasing, PlusNews reports. The annual District Health Barometer shows that about half of infants born to HIV-positive mothers are being tested for the virus at six weeks; almost all pregnant women are tested for HIV, helping to lower the rate of mother-to-child HIV transmission to below four percent nationwide; and about 70 percent of people newly diagnosed with HIV receive screening for tuberculosis (TB), according to the news service.
“India is lagging in its effort to reach United Nations goals to reduce poverty and improve health and sanitation, but has shown significant progress boosting education, treating AIDS and addressing environmental concerns,” Noeleen Heyzer, executive secretary of the U.N. Economic and Social Commission for Asia and the Pacific, said last week, the New York Times’ “India Ink” blog reports. According to an Asia Pacific Millennium Development Goal (MDG) report (.pdf) released last week, which “graded the progress of the eight millennium goals using 22 socio-economic indicators …, India has reached goals set in seven indicators out of 22 and is on track to achieve three others, but is lagging behind in 12,” the blog notes.
Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it “due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday” by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports (2/22). “At the launch of a new report called ‘Lives in the Balance,’ MSF said that only a quarter of the estimated 120,000 people living with HIV and AIDS were receiving treatment, and that it was turning people away from its clinics,” BBC News writes. While plans were made last year among MSF and its partners to scale up treatment for HIV and tuberculosis (TB), “those proposals were shelved after the Global Fund” to Fight AIDS, Tuberculosis and Malaria cancelled its Round 11 grants, according to the news agency. “The money was expected to provide HIV drugs for 46,500 people in Myanmar, along with treatment for another 10,000 people sicken[ed] by drug-resistant tuberculosis in the country, [the report] said,” BBC writes (Fisher, 2/22).
CBS News examines the fight against tuberculosis (TB) in South Korea, which “has the highest incidence rate of tuberculosis among the world’s wealthiest countries, nations [that] belong to the 34-member Organization for Economic Cooperation and Development (OECD).” The news service continues, “In 2010, South Korea’s incidence rate of tuberculosis was 97 out of 100,000, according to the World Health Organization (WHO), while the mortality rate of TB was 5.4 out of 100,000. (In the U.S., the incidence rate was 4.1 and the mortality rate was 0.18 during the same time period.)”
IRIN examines “whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of [tuberculosis (TB)] in developing countries.” The news service writes, “TB is a disease often associated with poverty because latent infections are more easily activated by malnutrition and lowered immune systems, and more quickly passed on in badly ventilated, overcrowded living conditions.”
In “the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis (TB) research and development,” the Center for Global Health Policy’s “Science Speaks” blog interviews Kayla Laserson, director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Laserson answers questions about her work with the CDC, the latest research projects underway at KEMRI/CDC, and progress in Kenya’s HIV response since she began working in Kisumu six years ago, among other topics (Mazzotta, 2/14).